Phlow Corp.
PrivateLast Round
Series C
Jul 22, 2025
Total Funding Raised
$447M
Company Overview
Phlow Corp. is a pharmaceutical company that provides contract development and manufacturing of active pharmaceutical ingredients and essential medicines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain, Smart Manufacturing, Clean Manufacturing, Supply Chain
Business Model
B2G
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Phlow Corp. Comparables
Compare Phlow Corp. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bright Path Laboratories | 88% | |
| CONTINUUS Pharmaceuticals | 81% | |
| Antheia | 79% |
For institutional investors. Book with your work email.
Phlow Corp. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jul 22, 2025 | ||||
| Series B | Apr 5, 2023 | ||||
| Series A | Feb 16, 2021 | ||||
| Grant | May 18, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Phlow Corp. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Public Health Emergency Medical Countermeasures Enterprise | Grant |
| Biomedical Advanced Research and Development Authority | Grant |
| Align Private Capital | Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 18, 2026
Dawn Von Rohr appointed as the new COO.
- Mar 18, 2026
Partnering with Fresenius Kabi for API production and final formulation.
For institutional investors. Book with your work email.
Phlow Corp. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Phlow Corp.'s valuation, stock price, and market status.
Is Phlow Corp. a public or private company?
Phlow Corp. is a private company.
What is the current stock price of Phlow Corp.?
Phlow Corp. is a private company, so its shares have no public market price. Caplight tracks Phlow Corp.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Phlow Corp. worth (valuation)?
Valuation information for Phlow Corp. is not publicly available.
Can I buy Phlow Corp. stock?
Phlow Corp. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Phlow Corp.'s last funding round?
Phlow Corp.'s most recent funding round was Series C on July 22, 2025.
Who are the main investors in Phlow Corp.?
Key investors in Phlow Corp. include Public Health Emergency Medical Countermeasures Enterprise, Biomedical Advanced Research and Development Authority, Align Private Capital.
Will Phlow Corp. IPO soon?
No public IPO plans have been announced for Phlow Corp..
How can I track Phlow Corp. secondary market activity?
Caplight tracks bids, offers, and trades in Phlow Corp.'s shares on secondary markets.